MarketResearchFuture.com published a Half-Cooked research report on “Global Women Healthcare Market Research Report – Forecast to 2023” reports to its database. – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.
YOU CAN GET ACCESS TO SAMPLES FROM THE REPORT HERE: https://www.marketresearchfuture.com/sample_request/3121 .
The market for women healthcare is projected to grow at a steady CAGR of 5.04% during the forecast period from 2017-2023.
The report titled “Women Healthcare Market -Forecast to 2023″ is a direct appreciation by Market Research Future of the market potential of the Women Healthcare Market. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today’s winner takes all market!
Global Women Healthcare Market – Overview:
Women health has been a concern from long period of time but past few years it has become an urgent priority for the whole world. Women’s health issues has now attracted the attention internationally. These concerns have taken the momentum rapidly when the United Nations’ has addressed the elimination of sex-based disparities in health care and reduction in maternal mortality in their Millennium Development Goals (MDG) by 2015.
Women’s lives have changed over the centuries, being a woman has many implications for health. Men and women share many similar health problems but some health problems are specific to women only. Women experience unique health issues and conditions from pregnancy and menopause to gynaecological conditions which affect the women’s health majorly. Many diseases occurred to women are caused due to poor health.
There are rising opportunities in the women’s healthcare market in the near future due to the rising issues affecting women such as breast cancer, urinary tract infections, anaemia, a bone-related disorder, cardiovascular diseases and osteoporosis among others. The early diagnosis of the diseases provides an important opportunity in this market especially in developing nations where awareness of preventive care is on the rise. In response to this market, the healthcare industry is progressively employing early diagnosis through screening and monitoring of the women health disorders. For screening of these diseases, hospitals, and screening centres worldwide are digitizing systems to optimize workflows and enhance image clarity for providing accurate diagnosis of the disease.
Global Women Healthcare Market – Major Players:
Allergan plc. (Ireland), Amgen (California), Bayer A G (Germany), Becton Dickinson and Company (U.S.), Eli Lilly Company (U.S.), Merck & Co., Inc., (U.S.), Pfizer Inc., (U.S.), Teva Pharmaceuticals (Israel), and others are some of the Prominent Players at the forefront of competition in the Global Women Healthcare Market and are profiled in MRFR Analysis.
Global Women Healthcare Market – Competitive Analysis:
March, 2017- Eli Lilly announced phase 3 MONARCH 2 Breast Cancer Trial with a goal of bringing abemaciclib to patients with advanced breast cancer. The Phase 3 study evaluated abemaciclib, a cyclin-dependent kinase (CDK) 4 and CDK 6 inhibitor, in combination with fulvestrant in women with hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), advanced breast cancer who have progressed after endocrine therapy. The results demonstrated the addition of abemaciclib to fulvestrant resulted in a statistically significant improvement in PFS (Progression-Free Survival), when compared to the control arm of placebo plus fulvestrant.
June 2016 – Merck (MSD) and Moderna have announced strategic collaboration to advance Novel mRNA-Based cancer vaccines with the help of Keytruda for the treatment of multiple types of cancer. This collaboration had established leadership in immuno-oncology with Moderna’s pioneering mRNA vaccine technology and GMP manufacturing capabilities to advance individually tailored cancer vaccines for patients across a spectrum of cancers. Moderna and Merck developed personalized cancer vaccines that utilize Moderna’s mRNA vaccine technology to encode a patient’s specific neoantigens, unique mutations present in that specific patient’s tumor. When injected into a patient, the vaccine will be designed to elicit a specific immune response that will recognize and destroy cancer cells.
September, 2016- Allergan and Richter had shown positive phase III results for Ulipristal acetate 5 and 10 mg in the treatment of uterine fibroids. Phase III study met all co-primary and secondary endpoints and achieved statistically significant results.
Global Women Healthcare Market – Regional Analysis:
North America is the largest market which accounted for 39.1% in 2016 of the global women healthcare market which is expected to grow at a CAGR of 4.5% during the forecast period. According to the Centers for Disease Control and Prevention (CDC) reports, in the U.S. approximately 12.5% of women older than 18 were considered to be in poor health in 2015. The rising prevalence of obesity is one of the key indicator which caused female specific health conditions. As per the World Health Organization (WHO), more than 1.9 billion adults aged 18 years and older were overweight and out of these over 600 million adults were obese ) in 2014. And this is the major cause of cardiovascular diseases, diabetes, musculoskeletal disorders, and some cancers such as endometrial, breast, ovarian among others. As per the study published in the journal JAMA reveals that for the years 2013-2014 the obesity prevalence was 35% for men and 40% for women in United States.
Global Women Healthcare Market – Segments:
The Women Healthcare Market is segmented on the basis of indications, diagnosis and treatment and also on the basis of end users. Based on the indications, the market has been segmented as postmenopausal osteoporosis, infertility, reproductive health management, polycystic ovary syndrome, gynecologic cancer and others. Gynecologic cancer segment has been further divided into breast, ovarian or other types of cancer. On the basis of diagnosis the market has been segmented as bone densitometry, diagnostic imaging tests, biopsies, ovulation testing and others. Similarly, on the basis of treatment the market has been classified as therapeutics, surgeries and others. Lastly on the basis of end users the market has been further classified into hospitals & clinics, gynecology centers, research institutes, and others
Global Women Healthcare Market – Market Assessment:
The report for Global women Healthcare Market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
…CONTINUED FOR TOC
FEEL FREE TO GET IN TOUCH FOR DISCOUNTS AND CUSTOMIZED DETAILS: https://www.marketresearchfuture.com/check-discount/3121 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –